Client Newsletter Example: Buffett Confirms Our June Analysis - Intel (INTC) Gets Government Bump - The Chemours Company (CC) Gets Cooling Technology Approval - Indexes Broaden Out

Published on August 15, 2025 @ 6:42am

Buffett confirms our analysis from June - read why below. Intel Corp. (INTC) gets a government bump - guess the CEO isn't a Chinese operative after all. The Chemours Company (CC) got some love from Samsung. Markets are starting to suggest it isn't all about AI and big tech. In fact, there's more value out there right now in other sectors. Just be mindful of hot trading bad actors. Here are the details on all of it:

Buffett Confirms Our June Analysis - Intel (INTC) Gets Government Bump - The Chemours Company (CC) Gets Cooling Technology Approval - Indexes Broaden Out

Most of you know by now we rarely tout our research and analysis, as we've always maintained an attitude of "we're only ever as good as our most recent idea." However, something happened yesterday that not only proves our fundamental research is solid, but also the type of research that even the biggest investment whales in the world can rely on.

I'm referring to Warren Buffett's 13-F SEC filing yesterday, which revealed his four biggest purchases for the second quarter. Specifically, he took positions totaling $3.4B in four companies: UnitedHealth (UNH), Nucor (NUE), Lennar (LEN), and D.R. Horton (DHI).

What does that have to do with us? I can honestly say there's probably not one research service out there that has mentioned Buffett's four biggest purchases during a particular month at the same time he and/or his firm were buying them, because if you don't know already, investors and firms like his do not reveal what they're buying until after they're done buying them.

With that, here are the excerpts from our newsletter around the same time Buffett was secretly buying. One has to admit, it is a little eerie, which is why I'm sharing this with you today:

In our June 4th newsletter edition, we said, "I think it goes without saying that the entire healthcare sector has been pretty much out of favor for quite some time now. Names like UnitedHealth Group Inc. (UNH), which we are finally a fan of owning a piece of now, have been beaten up badly for quite some time."

In our June 2nd newsletter edition, we said, "While we won't spend a whole lot of time today breaking down the future of steel stocks here in the U.S., we can tell you that Nucor Corp. (NUE) is the best and safest option for those interested in having forward exposure to the steel sector."

Then, in our June 17th edition, we said, "In summary, we're going to continue to stick with LEN for the time being. Not only is it among the best homebuilders in the country, but the entire housing sector does continue to remain down around somewhat oversold technical conditions. And considering equity markets are typically forward-looking, we do believe that most of the damage in stocks like Lennar Corp. (LEN), D.R. Horton, Inc. (DHI), and The Sherwin-Williams Company (SHW) have already been priced in."

While we will always do our best to cater to every type of trading and investing strategy (short-, mid-, and long-term), nothing we do will ever be as good as our ability to identify solid long-term investing ideas, as well as our ability to be close enough at calling long-term tops and bottoms. That has and will always continue to be the cornerstone of what we wake up and do for you every single day these markets are open.

It's important for everyone here to know that we only ever mention individual names here in the newsletter that we believe offer true fundamental merit. Are we always going to be right? Of course not, because at times we do profile certain small-cap stocks, which are always going to be risky. However, if there's anything we've clearly proven over the last few decades, it's that we know how to find value and potential before the rest of the herd.

We're not the type of service/firm that throws all kinds of stuff at the wall to see what sticks either. I'll leave that to the others. In fact, during the month of June, I'm fairly certain the only individual stocks (excluding ETFs) that we mentioned in our newsletter for both short- and long-term potential were UNH, NUE, DHI, LEN, SHW, NKE, ANET, RXRX, and GOOGL. So yes, Buffett was buying four out of the nine stocks we mentioned, and I think it goes without saying SHW, NKE, ANET, RXRX, and GOOGL have done well since.

In other words, we only ever mention or suggest an individual name here in the newsletter that we believe warrants your time and trading/investment attention. And yesterday's 13-F filing from Buffett proved that in spades. Oh, and by the way, Buffett's purchase of UNH may end up being good for one of our small-cap profile stocks, Oscar Health, Inc. (OSCR), as it is in the healthcare services sector as well.

In summary, stocks go up and stocks go down, and we're not always going to be right from a timing perspective, but in the end, our fundamental research is usually going to win, and that should always be the cornerstone of anyone's decision-making when it comes to investing or trading anything.

You also might know that we don't cover every single press release or news event on companies we suggest, not unless we believe the news is going to be fundamentally substantive for the company in question anyway.

Well, just yesterday, the Trump admin announced interest in the U.S. government possibly taking a stake in one of our ongoing open ideas, Intel Corp. (INTC). Specifically, the Trump administration is weighing the idea of taking an equity stake in Intel, a move aimed at bolstering the company's finances and accelerating progress on its long-delayed Ohio chip complex.

The discussions reportedly began after a White House meeting between President Trump and Intel's CEO, with the potential investment seen as a strategic push for U.S. semiconductor production. News of the talks sent Intel shares up about 7% in after-hours trading yesterday, but it has settled to only a modest gain so far this morning. The good news is it appears Trump no longer thinks Intel CEO Lip Bu Tang is a Chinese operative.

While I'm clearly attempting to be funny with that last line regarding Trump and Tang, if there's one thing everyone should have learned by now, it's not to buy into all of the noise in and around politics and the media these days. Just look at Tesla (TSLA) lately, another idea we love for the long haul. Point is, Trump is clearly a different type of leader than we've seen maybe ever, but his actions do speak louder than his words, and that's not to say I agree with every single action.

And finally, before I get into some very near-term analysis of the major indexes and what we're seeing there, one of our small-cap profile stocks, The Chemours Company (CC), had some potentially pivotal news a few days ago, which really turned the stock around.

Chemours reached a significant milestone when Samsung officially qualified its Opteon two-phase immersion cooling fluid for use with Samsung's current-generation SSDs, marking the first time such a product has earned this distinction.

Following extensive collaboration and real-world testing with partners in a 48-rack data-center setup, the fluid passed every compatibility benchmark without any degradation. The technology is designed to drastically cut energy and water usage, push PUE (Power Usage Effectiveness) close to 1, and reduce both space and cooling demands--positioning it as a game-changer for AI-driven, high-performance computing environments (datacenters).

The news two days ago sent shares of CC sharply higher, which tells us this "should" be the beginning of something good for Chemours. However, it's going to take a lot more of that exact same type of press to really start developing a much bigger bid for the stock. No hype, just facts.

As for the much broader equity landscape, it really does appear it's starting to broaden out, meaning many names that have been underwater for a long time are finally starting to perform. To be fair, however, we've seen this theme on the verge of developing before, only for the major indexes to start moving sharply lower again. This time around just might be different though.

I pointed everyone's attention here recently to the equal-weight ETFs, but if I had to pick one that paints the best picture of a potentially broadening out of the markets, it would be the Invesco S&P 500 Equal Weight ETF (RSP). Why? That ETF is made up of every single S&P 500 constituent, which includes all of your biggest and best technology names as well. However, every single constituent in this particular ETF is equally weighted, meaning it does not weight any one company more than another.

Provided here is a weekly chart in an effort to remove all of the short-term noise, and as you can see, it has finally managed to test its high this week. While that doesn't necessarily mean it's just going to start going higher and higher now, we are fairly certain that the test of its all-time highs this week is going to end up being successful.

In other words, no matter what happens in the days/weeks to come, we do believe these markets are going higher, and we do believe many other high-quality names are going to start participating a lot more than they have in recent years.

Therefore, we will continue to put our best fundamental foot forward and look to bring you a number of names that we've actually never mentioned here in the newsletter, or names we haven't mentioned in a very long time.

Have a great weekend, enjoy the time, and we'll see you right back here on Monday.

Open Buy List w/ Trade Parameters

Create a Free Trial Here To See Our Current Open Short-Term Trading Ideas: https://www.vikingcrest.com/register

Suggested Long-Term ETF Allocations

Create a Free Trial Here To See Which ETFs We Suggest Investors Maintain Long-Term Exposure To: https://www.vikingcrest.com/register

Important Strategy Tips On Trading, Investing and Portfolio Management: To review a list of rules and disciplines to consider go here: https://www.vikingcrest.com/article/88. It's a good idea to review this article from time-to-time for any newly added rules.

If you have any questions regarding a specific stock - even if it's something we haven't suggested - you can reply directly to this email, or call us at 619-369-9316. We're happy to help you better manage your portfolio any way we can.

John Monroe - Senior Editor and Analyst